HLA-DR β Antibodies

Santa Cruz Biotechnology offers a broad range of HLA-DR β monoclonal antibodies for immunology research. HLA-DR β monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HLA-DR β is a critical component of the major histocompatibility complex (MHC) class II molecules, playing a vital role in the immune response by presenting antigens to CD4+ T cells. The MHC class II molecules are essential for the activation of the adaptive immune system and are involved in various autoimmune diseases and transplant rejection processes. Understanding the function and regulation of HLA-DR β continues to be a key focus in immunological research. Investigating HLA-DR β expression patterns and interactions provides valuable insights into immune system regulation and potential therapeutic targets. Exploring HLA-DR β mechanisms helps advance our understanding of autoimmune conditions and transplant medicine. Santa Cruz Biotechnology monoclonal antibodies for HLA-DR β research support scientists in advancing immunological discoveries and developing innovative therapeutic strategies.